Delving into the Latest Updates on Guangdong Dexin Pharmaceutical Co., Ltd. with Synapse

Overview

Tags

Infectious Diseases

Urogenital Diseases

Herbal medicine

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Infectious Diseases	1

Top 5 Drug Type	Count

Herbal medicine	1

Through Phase III clinical trials, the clinical efficacy and safety of Jinshao Capsule in the treatment of qi stagnation, blood stasis and dampness obstruction syndrome in the sequelae of pelvic inflammatory disease (chronic pelvic inflammatory disease) were evaluated, the target indications were determined, and an important basis was provided for the clinical application of the drug.

Start Date11 Nov 2014

Sponsor / Collaborator

Guangdong Dexin Pharmaceutical Co., Ltd.

100 Clinical Results associated with Guangdong Dexin Pharmaceutical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Guangdong Dexin Pharmaceutical Co., Ltd.

Login to view more data

100 Deals associated with Guangdong Dexin Pharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Guangdong Dexin Pharmaceutical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 01 Mar 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 3

1

Login to view more data